Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Peptide glycosylation is a covalent modification that can potentially improve the physicochemical properties of peptides.
Some advantages of glycosylated peptides include: (1) increased bioavailability, (2) increased metabolic stability, (2) targeting specific tissues and organs, (3) reduction in clearance rates, (4) enhanced receptor binding, (5) facilitation of active transport across cell membranes (glucose transporters), and (6) maintaining the overall physical properties of peptides (precipitation, aggregation, thermal and kinetic denaturation).Glycopeptides are recognized as peptides that contain glycans (carbohydrate molecules) and can be generalized classified into three types based on the linkage or bond type between the amino acid and the glycan: (1) C-linked, (2) O-linked, and (3) N-linked.The most common type in eukaryotic cells is N-linked glycopeptides, noted by the C-N bond from the side chain of asparagine (Asn/N) amino acid. O-Type glycopeptides are named after the C-O bond from the side chains of serine (Ser) and threonine (Thr) amino acids. The least common C-linked types are recognized as the bond between a tryptophan residue and the sugar mannose.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Glycosylated Peptide market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Glycosylated Peptide market. Detailed analysis of key players, along with key growth strategies adopted by Glycosylated Peptide industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Medtronic
Pfizer
Cipla
Teva Pharmaceuticals Industries
Roche
Biocon
DrReddys Laboratories
Sandoz International
Celltrion
Bachem Americas
By Type:
Monoclonal Antibodies (MABs)
Erythropoietin (EPO)
Others
By End-User:
Oncology
Blood Disorder
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Glycosylated Peptide Market
-
1.3 Market Segment by Type
-
1.3.1 China Glycosylated Peptide Market Size and Growth Rate of Monoclonal Antibodies (MABs) from 2016 to 2027
-
1.3.2 China Glycosylated Peptide Market Size and Growth Rate of Erythropoietin (EPO) from 2016 to 2027
-
1.3.3 China Glycosylated Peptide Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Glycosylated Peptide Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.2 China Glycosylated Peptide Market Size and Growth Rate of Blood Disorder from 2016 to 2027
-
1.4.3 China Glycosylated Peptide Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Glycosylated Peptide Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Glycosylated Peptide by Major Types
-
3.4.1 Market Size and Growth Rate of Monoclonal Antibodies (MABs)
-
3.4.2 Market Size and Growth Rate of Erythropoietin (EPO)
-
3.4.3 Market Size and Growth Rate of Others
4 Segmentation of Glycosylated Peptide Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Glycosylated Peptide by Major End-Users
-
4.4.1 Market Size and Growth Rate of Glycosylated Peptide in Oncology
-
4.4.2 Market Size and Growth Rate of Glycosylated Peptide in Blood Disorder
-
4.4.3 Market Size and Growth Rate of Glycosylated Peptide in Others
5 Market Analysis by Regions
-
5.1 China Glycosylated Peptide Production Analysis by Regions
-
5.2 China Glycosylated Peptide Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Glycosylated Peptide Landscape Analysis
-
6.1 North China Glycosylated Peptide Landscape Analysis by Major Types
-
6.2 North China Glycosylated Peptide Landscape Analysis by Major End-Users
7 Central China Glycosylated Peptide Landscape Analysis
-
7.1 Central China Glycosylated Peptide Landscape Analysis by Major Types
-
7.2 Central China Glycosylated Peptide Landscape Analysis by Major End-Users
8 South China Glycosylated Peptide Landscape Analysis
-
8.1 South China Glycosylated Peptide Landscape Analysis by Major Types
-
8.2 South China Glycosylated Peptide Landscape Analysis by Major End-Users
9 East China Glycosylated Peptide Landscape Analysis
-
9.1 East China Glycosylated Peptide Landscape Analysis by Major Types
-
9.2 East China Glycosylated Peptide Landscape Analysis by Major End-Users
10 Northeast China Glycosylated Peptide Landscape Analysis
-
10.1 Northeast China Glycosylated Peptide Landscape Analysis by Major Types
-
10.2 Northeast China Glycosylated Peptide Landscape Analysis by Major End-Users
11 Southwest China Glycosylated Peptide Landscape Analysis
-
11.1 Southwest China Glycosylated Peptide Landscape Analysis by Major Types
-
11.2 Southwest China Glycosylated Peptide Landscape Analysis by Major End-Users
12 Northwest China Glycosylated Peptide Landscape Analysis
-
12.1 Northwest China Glycosylated Peptide Landscape Analysis by Major Types
-
12.2 Northwest China Glycosylated Peptide Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Medtronic
-
13.1.1 Medtronic Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Pfizer
-
13.2.1 Pfizer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Cipla
-
13.3.1 Cipla Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Teva Pharmaceuticals Industries
-
13.4.1 Teva Pharmaceuticals Industries Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Roche
-
13.5.1 Roche Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Biocon
-
13.6.1 Biocon Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 DrReddys Laboratories
-
13.7.1 DrReddys Laboratories Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Sandoz International
-
13.8.1 Sandoz International Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Celltrion
-
13.9.1 Celltrion Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Bachem Americas
-
13.10.1 Bachem Americas Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Glycosylated Peptide Market Size and Growth Rate of Monoclonal Antibodies (MABs) from 2016 to 2027
-
Figure China Glycosylated Peptide Market Size and Growth Rate of Erythropoietin (EPO) from 2016 to 2027
-
Figure China Glycosylated Peptide Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Glycosylated Peptide Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure China Glycosylated Peptide Market Size and Growth Rate of Blood Disorder from 2016 to 2027
-
Figure China Glycosylated Peptide Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Glycosylated Peptide Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Glycosylated Peptide Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Glycosylated Peptide
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Glycosylated Peptide by Different Types from 2016 to 2027
-
Table Consumption Share of Glycosylated Peptide by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Monoclonal Antibodies (MABs)
-
Figure Market Size and Growth Rate of Erythropoietin (EPO)
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Glycosylated Peptide by Different End-Users from 2016 to 2027
-
Table Consumption Share of Glycosylated Peptide by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Blood Disorder
-
Figure Market Size and Growth Rate of Others
-
Table China Glycosylated Peptide Production by Regions
-
Table China Glycosylated Peptide Production Share by Regions
-
Figure China Glycosylated Peptide Production Share by Regions in 2016
-
Figure China Glycosylated Peptide Production Share by Regions in 2021
-
Figure China Glycosylated Peptide Production Share by Regions in 2027
-
Table China Glycosylated Peptide Consumption by Regions
-
Table China Glycosylated Peptide Consumption Share by Regions
-
Figure China Glycosylated Peptide Consumption Share by Regions in 2016
-
Figure China Glycosylated Peptide Consumption Share by Regions in 2021
-
Figure China Glycosylated Peptide Consumption Share by Regions in 2027
-
Table North China Glycosylated Peptide Consumption by Types from 2016 to 2027
-
Table North China Glycosylated Peptide Consumption Share by Types from 2016 to 2027
-
Figure North China Glycosylated Peptide Consumption Share by Types in 2016
-
Figure North China Glycosylated Peptide Consumption Share by Types in 2021
-
Figure North China Glycosylated Peptide Consumption Share by Types in 2027
-
Table North China Glycosylated Peptide Consumption by End-Users from 2016 to 2027
-
Table North China Glycosylated Peptide Consumption Share by End-Users from 2016 to 2027
-
Figure North China Glycosylated Peptide Consumption Share by End-Users in 2016
-
Figure North China Glycosylated Peptide Consumption Share by End-Users in 2021
-
Figure North China Glycosylated Peptide Consumption Share by End-Users in 2027
-
Table Central China Glycosylated Peptide Consumption by Types from 2016 to 2027
-
Table Central China Glycosylated Peptide Consumption Share by Types from 2016 to 2027
-
Figure Central China Glycosylated Peptide Consumption Share by Types in 2016
-
Figure Central China Glycosylated Peptide Consumption Share by Types in 2021
-
Figure Central China Glycosylated Peptide Consumption Share by Types in 2027
-
Table Central China Glycosylated Peptide Consumption by End-Users from 2016 to 2027
-
Table Central China Glycosylated Peptide Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Glycosylated Peptide Consumption Share by End-Users in 2016
-
Figure Central China Glycosylated Peptide Consumption Share by End-Users in 2021
-
Figure Central China Glycosylated Peptide Consumption Share by End-Users in 2027
-
Table South China Glycosylated Peptide Consumption by Types from 2016 to 2027
-
Table South China Glycosylated Peptide Consumption Share by Types from 2016 to 2027
-
Figure South China Glycosylated Peptide Consumption Share by Types in 2016
-
Figure South China Glycosylated Peptide Consumption Share by Types in 2021
-
Figure South China Glycosylated Peptide Consumption Share by Types in 2027
-
Table South China Glycosylated Peptide Consumption by End-Users from 2016 to 2027
-
Table South China Glycosylated Peptide Consumption Share by End-Users from 2016 to 2027
-
Figure South China Glycosylated Peptide Consumption Share by End-Users in 2016
-
Figure South China Glycosylated Peptide Consumption Share by End-Users in 2021
-
Figure South China Glycosylated Peptide Consumption Share by End-Users in 2027
-
Table East China Glycosylated Peptide Consumption by Types from 2016 to 2027
-
Table East China Glycosylated Peptide Consumption Share by Types from 2016 to 2027
-
Figure East China Glycosylated Peptide Consumption Share by Types in 2016
-
Figure East China Glycosylated Peptide Consumption Share by Types in 2021
-
Figure East China Glycosylated Peptide Consumption Share by Types in 2027
-
Table East China Glycosylated Peptide Consumption by End-Users from 2016 to 2027
-
Table East China Glycosylated Peptide Consumption Share by End-Users from 2016 to 2027
-
Figure East China Glycosylated Peptide Consumption Share by End-Users in 2016
-
Figure East China Glycosylated Peptide Consumption Share by End-Users in 2021
-
Figure East China Glycosylated Peptide Consumption Share by End-Users in 2027
-
Table Northeast China Glycosylated Peptide Consumption by Types from 2016 to 2027
-
Table Northeast China Glycosylated Peptide Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Glycosylated Peptide Consumption Share by Types in 2016
-
Figure Northeast China Glycosylated Peptide Consumption Share by Types in 2021
-
Figure Northeast China Glycosylated Peptide Consumption Share by Types in 2027
-
Table Northeast China Glycosylated Peptide Consumption by End-Users from 2016 to 2027
-
Table Northeast China Glycosylated Peptide Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Glycosylated Peptide Consumption Share by End-Users in 2016
-
Figure Northeast China Glycosylated Peptide Consumption Share by End-Users in 2021
-
Figure Northeast China Glycosylated Peptide Consumption Share by End-Users in 2027
-
Table Southwest China Glycosylated Peptide Consumption by Types from 2016 to 2027
-
Table Southwest China Glycosylated Peptide Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Glycosylated Peptide Consumption Share by Types in 2016
-
Figure Southwest China Glycosylated Peptide Consumption Share by Types in 2021
-
Figure Southwest China Glycosylated Peptide Consumption Share by Types in 2027
-
Table Southwest China Glycosylated Peptide Consumption by End-Users from 2016 to 2027
-
Table Southwest China Glycosylated Peptide Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Glycosylated Peptide Consumption Share by End-Users in 2016
-
Figure Southwest China Glycosylated Peptide Consumption Share by End-Users in 2021
-
Figure Southwest China Glycosylated Peptide Consumption Share by End-Users in 2027
-
Table Northwest China Glycosylated Peptide Consumption by Types from 2016 to 2027
-
Table Northwest China Glycosylated Peptide Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Glycosylated Peptide Consumption Share by Types in 2016
-
Figure Northwest China Glycosylated Peptide Consumption Share by Types in 2021
-
Figure Northwest China Glycosylated Peptide Consumption Share by Types in 2027
-
Table Northwest China Glycosylated Peptide Consumption by End-Users from 2016 to 2027
-
Table Northwest China Glycosylated Peptide Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Glycosylated Peptide Consumption Share by End-Users in 2016
-
Figure Northwest China Glycosylated Peptide Consumption Share by End-Users in 2021
-
Figure Northwest China Glycosylated Peptide Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Medtronic
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medtronic
-
Figure Sales and Growth Rate Analysis of Medtronic
-
Figure Revenue and Market Share Analysis of Medtronic
-
Table Product and Service Introduction of Medtronic
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Cipla
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla
-
Figure Sales and Growth Rate Analysis of Cipla
-
Figure Revenue and Market Share Analysis of Cipla
-
Table Product and Service Introduction of Cipla
-
Table Company Profile and Development Status of Teva Pharmaceuticals Industries
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals Industries
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals Industries
-
Figure Revenue and Market Share Analysis of Teva Pharmaceuticals Industries
-
Table Product and Service Introduction of Teva Pharmaceuticals Industries
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
-
Figure Sales and Growth Rate Analysis of Biocon
-
Figure Revenue and Market Share Analysis of Biocon
-
Table Product and Service Introduction of Biocon
-
Table Company Profile and Development Status of DrReddys Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of DrReddys Laboratories
-
Figure Sales and Growth Rate Analysis of DrReddys Laboratories
-
Figure Revenue and Market Share Analysis of DrReddys Laboratories
-
Table Product and Service Introduction of DrReddys Laboratories
-
Table Company Profile and Development Status of Sandoz International
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International
-
Figure Sales and Growth Rate Analysis of Sandoz International
-
Figure Revenue and Market Share Analysis of Sandoz International
-
Table Product and Service Introduction of Sandoz International
-
Table Company Profile and Development Status of Celltrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
-
Figure Sales and Growth Rate Analysis of Celltrion
-
Figure Revenue and Market Share Analysis of Celltrion
-
Table Product and Service Introduction of Celltrion
-
Table Company Profile and Development Status of Bachem Americas
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bachem Americas
-
Figure Sales and Growth Rate Analysis of Bachem Americas
-
Figure Revenue and Market Share Analysis of Bachem Americas
-
Table Product and Service Introduction of Bachem Americas
-
